DK0787007T3 - Antiinflammatorisk faktor, isoleringsfremgangsmåde og anvendelse - Google Patents

Antiinflammatorisk faktor, isoleringsfremgangsmåde og anvendelse

Info

Publication number
DK0787007T3
DK0787007T3 DK95933752T DK95933752T DK0787007T3 DK 0787007 T3 DK0787007 T3 DK 0787007T3 DK 95933752 T DK95933752 T DK 95933752T DK 95933752 T DK95933752 T DK 95933752T DK 0787007 T3 DK0787007 T3 DK 0787007T3
Authority
DK
Denmark
Prior art keywords
inflammatory factor
isolation method
methods
factor
cells
Prior art date
Application number
DK95933752T
Other languages
English (en)
Inventor
Lee R Beck
J Peter Fuhrer
Original Assignee
Stolle Milk Biologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Milk Biologics Inc filed Critical Stolle Milk Biologics Inc
Application granted granted Critical
Publication of DK0787007T3 publication Critical patent/DK0787007T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK95933752T 1994-10-03 1995-09-08 Antiinflammatorisk faktor, isoleringsfremgangsmåde og anvendelse DK0787007T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/316,474 US5650175A (en) 1982-06-03 1994-10-03 Anti-inflammatory factor, method of isolation, and use
PCT/US1995/011398 WO1996010410A1 (en) 1994-10-03 1995-09-08 Anti-inflammatory factor, method of isolation, and use

Publications (1)

Publication Number Publication Date
DK0787007T3 true DK0787007T3 (da) 2002-04-22

Family

ID=23229212

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95933752T DK0787007T3 (da) 1994-10-03 1995-09-08 Antiinflammatorisk faktor, isoleringsfremgangsmåde og anvendelse

Country Status (19)

Country Link
US (1) US5650175A (da)
EP (1) EP0787007B1 (da)
JP (2) JP4234197B2 (da)
KR (1) KR100424403B1 (da)
AT (1) ATE211916T1 (da)
AU (1) AU692608B2 (da)
CA (1) CA2201106C (da)
DE (1) DE69525060T2 (da)
DK (1) DK0787007T3 (da)
ES (1) ES2170809T3 (da)
FI (1) FI120574B (da)
HK (1) HK1000552A1 (da)
IL (1) IL115293A (da)
MX (1) MX9702398A (da)
NO (1) NO318921B1 (da)
NZ (2) NZ333653A (da)
PT (1) PT787007E (da)
TW (1) TW410157B (da)
WO (1) WO1996010410A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980953A (en) * 1994-10-03 1999-11-09 Stolle Milk Biologics, Inc. Anti-inflammatory factor, method of isolation, and use
JP2001342127A (ja) * 2000-06-02 2001-12-11 Nomoto Kikuo 腸吸収性抗炎症因子含有免疫性物質及びその応用
US6770280B1 (en) 2001-11-15 2004-08-03 Humanetics Corporation Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product
US20110183052A1 (en) * 2004-10-07 2011-07-28 Next Proteins, Inc. Protein beverage and method of making the same
US20080206415A1 (en) * 2004-10-07 2008-08-28 Next Proteins, Inc. Protein beverage and method of making the same
US9220292B2 (en) 2004-10-07 2015-12-29 Next Problems, Inc. Protein beverage and method of making same
US20070025980A1 (en) * 2005-07-27 2007-02-01 Krogsgaard David L Composition permitting muscle growth while protecting joint health
US20080026983A1 (en) * 2006-07-28 2008-01-31 Gardiner Paul T Compositions and methods for alleviating joint pain and improving joint flexibility

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128230A (en) * 1961-04-04 1964-04-07 Sunbury Milk Products Co Milk having antibodies therein and process for producing same
US3376198A (en) * 1965-07-21 1968-04-02 Collins Products Inc Method of producing antibodies in milk
GB1211876A (en) * 1967-11-23 1970-11-11 Twyford Lab Ltd Improvements in and relating to prophylactic and therapeutic preparations
CH590064A5 (da) * 1973-11-28 1977-07-29 Biokema Sa
US4324782A (en) * 1974-01-28 1982-04-13 Beck Lee R Dental caries inhibiting product of immunized cow's milk having antibodies specific to killed Streptococcus mutans cells
US4732757A (en) * 1978-02-06 1988-03-22 Stolle Research And Development Corporation Prevention and treatment of rheumatoid arthritis
US4284623A (en) * 1979-11-09 1981-08-18 Beck Lee R Method of treating inflammation using bovine milk
DE3172807D1 (en) * 1981-04-28 1985-12-12 Stolle Res & Dev Method of obtaining an anti-inflammatory bovine milk
US4897265A (en) * 1983-10-27 1990-01-30 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
US5242691A (en) * 1982-06-03 1993-09-07 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US4956349A (en) * 1983-10-27 1990-09-11 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5352462A (en) * 1982-06-03 1994-10-04 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
EP0300102B1 (en) * 1987-07-21 1993-03-24 The Stolle Research And Development Corporation Improved method of obtaining immune regulatory factors by mammal immunization

Also Published As

Publication number Publication date
IL115293A0 (en) 1995-12-31
DE69525060D1 (de) 2002-02-21
AU3628295A (en) 1996-04-26
NZ293763A (en) 1999-02-25
FI120574B (fi) 2009-12-15
JPH10509420A (ja) 1998-09-14
IL115293A (en) 2000-12-06
ATE211916T1 (de) 2002-02-15
NZ333653A (en) 2000-08-25
NO971474L (no) 1997-06-03
JP2008133299A (ja) 2008-06-12
NO971474D0 (no) 1997-04-01
MX9702398A (es) 1997-06-28
EP0787007B1 (en) 2002-01-16
JP4234197B2 (ja) 2009-03-04
WO1996010410A1 (en) 1996-04-11
EP0787007A1 (en) 1997-08-06
US5650175A (en) 1997-07-22
HK1000552A1 (en) 2002-06-07
PT787007E (pt) 2002-07-31
TW410157B (en) 2000-11-01
NO318921B1 (no) 2005-05-23
FI971245A0 (fi) 1997-03-25
FI971245L (fi) 1997-05-28
CA2201106A1 (en) 1996-04-11
CA2201106C (en) 2010-03-23
ES2170809T3 (es) 2002-08-16
DE69525060T2 (de) 2002-11-14
KR100424403B1 (ko) 2004-05-20
KR970706008A (ko) 1997-11-03
AU692608B2 (en) 1998-06-11

Similar Documents

Publication Publication Date Title
CA2254871A1 (en) Purification of biologically active peptides from milk
EP1045635A4 (en) CLONING USING DIFFERENTIATED FETAL CELLS AND ADULT CELLS
UA29421C2 (uk) Спосіб виділення фактора vііі з інших білків в плазмі крові
WO2000069896A3 (en) Molecular interactions in haematopoietic cells
NO951570D0 (no) Anti-inflammatorisk faktor, fremgangsmåte for isolering derav og anvendelse
NO971474D0 (no) Anti-inflammatorisk faktor, fremgangsmåte for isolering, og anvendelse
ITFI920078A0 (it) Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umana.
IT1266734B1 (it) Gruppo per la molatura di lastre di vetro.
ES8404514A1 (es) Procedimiento para obtener un polipeptido con efecto sobre el sistema de inmunidad
MY117908A (en) Anti-inflammatory factor, method of isolation, and use
IT8622548A0 (it) Procedimento d'epurazione e di deodorizzazione di gas e installazione per la messa in opera di questo procedimento.
ATE207498T1 (de) Neutrophilen inhibitoren aus nematoden
GR930100408A (el) Μέ?οδος απομόνωσης και κα?αρισμού μεβινολίνης.
FI914049A7 (fi) Menetelmä entsyymien erottamiseksi entsyymipitoisista liuoksista
FI952292L (fi) Menetelmä kiinteiden materiaalien erottamiseksi mikro-organismeista
WO2000069898A8 (en) Molecular interactions in allergy cells
ITRM920385A0 (it) Procedimento per la purificazione di proteine da sistemi cellulari.
IT8285511A0 (it) Procedimento per l'estrazione e purificazione delle proteine, sotto forma di polipeptidi solubili, dagli scarti di conceria.
ITPA930012A0 (it) Metodo per l'eliminazione del mal di testa.
MX9603369A (es) Aisalmiento de lactoferrina a partir de leche.
IT8020543A0 (it) Dispositivo per l'applicazione dilastre di vetro multiple su serramenti in genere.
IT8021135V0 (it) Dispositivo per l'applicazione di lastre di vetro multiple su serramenti in genere.